Hack Andrew A. F.

Average Profitability
28.87%
Insider Buys Quantity
21
Insider Buys Sum
$143.81M
Insider Sells Quantity
30
Insider Sells Sum
$360.02M

Insider Activity of Hack Andrew A. F.

According to the SEC Form 4 filings, Hack Andrew A. F., being in a position of

  1. director at Nuvalent, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2130000 shares for $174.04M,
    over all time since 2021-08-02, has bought 1768506 shares for $34.99M, and sold 2130000 shares for $174.04M.

The largest purchase of all time was on 2020-04-07 and amounted to 6891334 shares of Mersana Therapeutics, Inc. for $41.3M.

The largest sale of all time was on 2024-12-11 and amounted to 1250000 shares of Nuvalent, Inc. for $110M.

Biography of Hack Andrew A. F.

No biography is available at this moment.

2024-12-11SaleNuvalent, Inc.
NUVL
director
1.25M
1.6417%
$88.00$110M-7.21%
2024-03-27SaleNuvalent, Inc.
NUVL
director
880,000
1.3042%
$72.77$64.04M+5.28%
2023-08-08SaleDynavax Technologies Corporation
DVAX
director
1.5M
1.1284%
$14.39$21.59M-11.69%
2023-06-14SaleDynavax Technologies Corporation
DVAX
director
500,000
0.3927%
$12.68$6.34M+6.26%
2023-05-18SaleDynavax Technologies Corporation
DVAX
director
1M
0.7525%
$10.55$10.55M+22.38%
2022-12-06SaleDynavax Technologies Corporation
DVAX
director
1.5M
1.4875%
$11.60$17.4M+1.85%
2022-11-03PurchaseNuvalent, Inc.
NUVL
director
298,506
0.6374%
$33.50$10M+32.21%
2022-08-15SaleDynavax Technologies Corporation
DVAX
3M
2.219%
$14.68$44.04M-27.66%
2022-05-31PurchaseMersana Therapeutics, Inc.
MRSN
14,760
0.0148%
$3.20$47,182+90.72%
2022-05-24PurchaseMersana Therapeutics, Inc.
MRSN
75,000
0.0765%
$3.19$238,943+88.96%
2022-05-23PurchaseMersana Therapeutics, Inc.
MRSN
director
15,599
0.0162%
$3.35$52,247+83.04%
2022-05-20PurchaseMersana Therapeutics, Inc.
MRSN
director
100,000
0.1034%
$3.46$345,570+75.07%
2022-05-19PurchaseMersana Therapeutics, Inc.
MRSN
115,599
0.1213%
$3.47$400,867+76.52%
2022-05-18PurchaseMersana Therapeutics, Inc.
MRSN
director
211,268
0.2245%
$3.35$707,262+84.19%
2022-05-17PurchaseMersana Therapeutics, Inc.
MRSN
director
3,440
0.0034%
$3.18$10,952+79.82%
2022-05-16PurchaseMersana Therapeutics, Inc.
MRSN
138,732
0.1441%
$3.10$430,398+93.91%
2022-04-13PurchaseMersana Therapeutics, Inc.
MRSN
1.23M
1.1527%
$4.05$5M+28.04%
2022-04-12PurchaseMersana Therapeutics, Inc.
MRSN
1.2M
1.3086%
$4.18$5M+45.36%
2022-02-07PurchaseMersana Therapeutics, Inc.
MRSN
director
2.27M
2.7929%
$4.42$10.05M+25.11%
2021-12-30PurchaseMersana Therapeutics, Inc.
MRSN
director
1.63M
2.2192%
$6.15$10.02M-17.11%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.